查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1707059

2025年全球治療性血漿置換市場報告

Therapeutic Plasma Exchange Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 200 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年治療性血漿置換市場規模將強勁成長。到 2029 年，這一數字將成長至 23.2 億美元，複合年成長率為 9.5%。預測期內的成長可歸因於老年人口、臨床證據和指南、法規環境、醫院基礎設施和醫療保健投資、醫療保健支出和報銷政策的增加。預測期內的主要趨勢包括個人化護理、自動化整合、協作舉措和遠端醫療整合。

預計血液疾病盛行率的不斷上升將推動未來治療性血漿置換市場的擴張。血液疾病（血液疾病）包括影響血液和造血組織（如骨髓、淋巴結和脾臟）的疾病。這些疾病的增加是由於遺傳傾向、環境影響和生活方式改變等因素所造成的。治療性血漿置換 (TPE) 用於治療血液疾病，透過去除血漿中的致病物質，例如自體免疫溶血性貧血中的自身抗體和血栓性血小板低下紫斑症中的免疫複合物，從而減輕疾病的嚴重程度並改善患者的預後。例如，2023年8月，美國專業組織白血病和淋巴瘤協會預測，從2021年到2023年，骨髓瘤診斷數量將增加約2.3%，分別從34,920例增加到35,730例。因此，血液疾病的高盛行率正在推動治療性血漿置換市場的成長。

2022年7月，美國科技公司Terumo Corporation Blood and Cell Technologies與專門從事用於治療發炎和腎臟相關疾病的血液分離術的美國醫療器材公司Areas 醫療設備建立策略夥伴關係。此次合作的重點是透過選擇性地從血漿中去除發炎蛋白 Gal-3 來解決急性腎損傷 (AKI) 和膿毒症引起的 AKI (S-AKI)。此次合作旨在利用Terumo Corporation的 Spectra Optia 單採系統和 Eliaz Therapeutics 的 XGal-3管柱探索新型療法。鑑於 AKI 的高死亡率，此次夥伴關係的初步研究將在大型動物身上進行，然後再進行人體臨床試驗。 Terumo Corporation以其在治療性血液分離方面的專業知識而聞名，此前曾合作開展針對三陰性乳癌和 COVID-19 等疾病的計劃。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場 - 宏觀經濟情景，包括利率、感染疾病、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球治療性血漿置換PESTEL分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 最終用途產業分析
  • 全球治療性血漿置換市場：成長率分析
  • 全球治療性血漿置換市場表現：規模與成長，2019-2024
  • 全球治療性血漿置換市場預測：規模與成長，2024-2029 年，2034 年
  • 全球治療性血漿置換總目標市場（TAM）

第6章市場區隔

  • 全球治療性血漿置換市場類型、績效及預測（2019-2024 年、2024-2029 年及 2034 年）
  • 治療性血漿置換（TPE）
  • 雙重過濾血漿置換術（DFPP）
  • 全球治療性血漿置換市場（依適應症、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 神經系統疾病
  • 血液系統疾病
  • 腎臟疾病
  • 代謝紊亂
  • 其他適應症
  • 全球治療性血漿置換市場（依技術、績效及預測），2019-2024 年、2024-2029 年及 2034 年
  • 離心
  • 膜分離
  • 全球治療性血漿置換市場（依最終使用者、績效及預測），2019-2024 年、2024-2029 年及 2034 年
  • 血液採集中心
  • 醫院和診所
  • 輸血中心
  • 其他最終用戶
  • 全球治療性血漿置換市場、治療性血漿置換 (TPE) 細分市場、按類型、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 手動TPE
  • 自動化TPE
  • 全球治療性血漿置換市場雙濾血漿置換（DFPP）類型細分、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 單級DFPP
  • 多階段DFPP

第7章 區域和國家分析

  • 全球治療性血漿置換市場：依地區、績效及預測，2019-2024 年、2024-2029 年、2034 年
  • 全球治療性血漿置換市場：依國家、地區、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 治療性血漿置換市場：競爭格局
  • 治療性血漿置換市場：公司簡介
    • Medica SpA Overview, Products and Services, Strategy and Financial Analysis
    • Fresenius SE and Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic Plc. Overview, Products and Services, Strategy and Financial Analysis
    • Asahi Kasei Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Toray Industries Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Baxter International Inc.
  • B Braun Melsungen AG
  • Terumo Corporation
  • Kaneka Corporation
  • Charles River Laboratories
  • Octapharma AG
  • Spectral Medical Inc.
  • Nikkiso Co. Ltd.
  • Haemonetics Corporation
  • Miltenyi Biotec Technology And Trading Co. Ltd.
  • Macopharma SA
  • Cerus Corporation
  • Apellis Pharmaceuticals Inc.
  • ImmunoTek Bio Centers LLC
  • CytoSorbents Corporation

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年治療性血漿置換市場：提供新機會的國家
  • 2029年治療性血漿置換市場：細分領域帶來新機會
  • 2029年治療性血漿置換市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r31384

Therapeutic plasma exchange (TPE) is a medical intervention utilized in the treatment of specific autoimmune diseases and other medical conditions. In this procedure, blood is extracted from the body, the plasma component (the fluid part of blood) is separated from the blood cells, and the blood cells are subsequently reintroduced into the body, often after being mixed with a replacement fluid. This method aids in eliminating harmful substances from the bloodstream, such as autoantibodies or toxins, which are implicated in various diseases.

The primary modalities of therapeutic plasma exchange include therapeutic plasma exchange (TPE) and double-filtered plasmapheresis (DFPP). Therapeutic Plasma Exchange (TPE) is a clinical process that involves removing plasma from the blood and substituting it with a replacement fluid, facilitating the elimination of detrimental substances or excess components. This procedure finds application in diverse medical conditions such as neurological disorders, hematological disorders, renal disorders, metabolic disorders, among others. Various technologies, including centrifugation and membrane separation, are employed in this process, catering to a range of end users such as blood collection centers, hospitals and clinics, transfusion centers, and others.

The therapeutic plasma exchange market research report is one of a series of new reports from The Business Research Company that provides therapeutic plasma exchange market statistics, including therapeutic plasma exchange industry global market size, regional shares, competitors with a therapeutic plasma exchange market share, detailed therapeutic plasma exchange market segments, market trends and opportunities, and any further data you may need to thrive in the therapeutic plasma exchange industry. This therapeutic plasma exchange market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The therapeutic plasma exchange market size has grown strongly in recent years. It will grow from $1.47 billion in 2024 to $1.62 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to the emergence of immunological diseases, increasing technological advancements, increased awareness and education, expanded indications, and improved understanding of the pathophysiology.

The therapeutic plasma exchange market size is expected to see strong growth in the next few years. It will grow to $2.32 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to the rising geriatric population, clinical evidence and guidelines, regulatory environment, hospital infrastructure and healthcare investments, healthcare expenditure, and reimbursement policies. Major trends in the forecast period include personalized therapies, integration of automation, collaborative initiatives, and telemedicine integration.

The increasing prevalence of hematological disorders is poised to drive the expansion of the therapeutic plasma exchange market in the future. Hematological disorders, or blood disorders, encompass medical conditions affecting blood and blood-forming tissues such as bone marrow, lymph nodes, and spleen. The rise in these disorders is attributed to factors such as genetic predispositions, environmental influences, and changes in lifestyle. Therapeutic plasma exchange (TPE) is employed in managing hematological disorders by removing pathogenic substances from the plasma, such as autoantibodies in autoimmune hemolytic anemia or immune complexes in thrombotic thrombocytopenic purpura, thus alleviating disease severity and enhancing patient outcomes. For example, in August 2023, as per the Leukemia and Lymphoma Society, a US-based professional organization, the projected number of myeloma diagnoses is expected to increase by approximately 2.3% from 2021 to 2023, rising from 34,920 to 35,730, respectively. Hence, the high prevalence of hematological disorders is fueling the growth of the therapeutic plasma exchange market.

In July 2022, Terumo Blood and Cell Technologies, a US-based technology company, formed a strategic partnership with Eliaz Therapeutics Inc., a US-based medical device company specializing in therapeutic apheresis for inflammatory and kidney-related conditions. This collaboration focuses on addressing acute kidney injury (AKI) and sepsis-induced AKI (S-AKI) by selectively removing the inflammatory protein Gal-3 from blood plasma. The partnership aims to explore novel treatments using Terumo's Spectra Optia Apheresis System and Eliaz Therapeutics' XGal-3 column. Given the high mortality rates associated with AKI, the partnership's initial studies will be conducted in large animals before progressing to human clinical trials. Terumo is known for its expertise in therapeutic apheresis and has previously collaborated on projects targeting conditions such as triple-negative breast cancer and COVID-19.

In July 2022, Discovery Life Sciences, Inc., a US-based provider of biospecimen analysis services, acquired AllCells for an undisclosed amount. This strategic acquisition aims to create a leading global provider of critical starting materials and analytic services, enhancing the development of cell and gene therapies (CGT) across the entire continuum-from discovery to commercialization. AllCells, a US-based company, specializes in providing clinical-grade and research-use primary cell products, including plasma exchange or plasmapheresis services. The acquisition is expected to strengthen Discovery Life Sciences' capabilities in supporting CGT development, positioning the company as a key player in the biotechnology and healthcare sectors.

Major companies operating in the therapeutic plasma exchange market are Medica S.p.A., Fresenius SE and Co. KGaA, Medtronic Plc., Asahi Kasei Corporation, Toray Industries Inc., Baxter International Inc., B Braun Melsungen AG, Terumo Corporation, Kaneka Corporation, Charles River Laboratories, Octapharma AG, Spectral Medical Inc., Nikkiso Co. Ltd., Haemonetics Corporation, Miltenyi Biotec Technology And Trading Co. Ltd., Macopharma SA, Cerus Corporation, Apellis Pharmaceuticals Inc., ImmunoTek Bio Centers LLC, CytoSorbents Corporation, Kawasumi Laboratories America Inc., Japan Medical Supply Co. Ltd.

North America was the largest region in the therapeutic plasma exchange market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the therapeutic plasma exchange market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the therapeutic plasma exchange market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The therapeutic plasma exchange market consists of revenues earned by entities by providing services such as patient evaluation, treatment planning, medical monitoring, and plasma separation. The market value includes the value of related goods sold by the service provider or included within the service offering. The therapeutic plasma exchange market also includes the sale of plasma separators, replacement fluids, anticoagulants, catheters and access devices, disposable consumables, and monitoring equipment. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Therapeutic Plasma Exchange Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on therapeutic plasma exchange market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for therapeutic plasma exchange ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The therapeutic plasma exchange market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Therapeutic Plasma Exchange (TPE); Double Filtered Plasmapheresis (DFPP)
  • 2) By Indication: Neurological Disorders; Hematological Disorders; Renal Disorders; Metabolic Disorders; Other Indications
  • 3) By Technology: Centrifugation; Membrane Separation
  • 4) By End User: Blood Collection Centers; Hospitals And Clinics; Transfusion Centers; Other End Users
  • Subsegments:
  • 1) By Therapeutic Plasma Exchange (Tpe): Manual Tpe; Automated Tpe
  • 2) By Double Filtered Plasmapheresis (Dfpp): Single-Stage Dfpp; Multi-Stage Dfpp
  • Companies Mentioned: Medica S.p.A.; Fresenius SE and Co. KGaA; Medtronic Plc.; Asahi Kasei Corporation; Toray Industries Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Therapeutic Plasma Exchange Market Characteristics

3. Therapeutic Plasma Exchange Market Trends And Strategies

4. Therapeutic Plasma Exchange Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Therapeutic Plasma Exchange Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Therapeutic Plasma Exchange PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Therapeutic Plasma Exchange Market Growth Rate Analysis
  • 5.4. Global Therapeutic Plasma Exchange Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Therapeutic Plasma Exchange Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Therapeutic Plasma Exchange Total Addressable Market (TAM)

6. Therapeutic Plasma Exchange Market Segmentation

  • 6.1. Global Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Therapeutic Plasma Exchange (TPE)
  • Double Filtered Plasmapheresis (DFPP)
  • 6.2. Global Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Neurological Disorders
  • Hematological Disorders
  • Renal Disorders
  • Metabolic Disorders
  • Other Indications
  • 6.3. Global Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Centrifugation
  • Membrane Separation
  • 6.4. Global Therapeutic Plasma Exchange Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Blood Collection Centers
  • Hospitals And Clinics
  • Transfusion Centers
  • Other End Users
  • 6.5. Global Therapeutic Plasma Exchange Market, Sub-Segmentation Of Therapeutic Plasma Exchange (TPE), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Manual TPE
  • Automated TPE
  • 6.6. Global Therapeutic Plasma Exchange Market, Sub-Segmentation Of Double Filtered Plasmapheresis (DFPP), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Single-Stage DFPP
  • Multi-Stage DFPP

7. Therapeutic Plasma Exchange Market Regional And Country Analysis

  • 7.1. Global Therapeutic Plasma Exchange Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Therapeutic Plasma Exchange Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Therapeutic Plasma Exchange Market

  • 8.1. Asia-Pacific Therapeutic Plasma Exchange Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Therapeutic Plasma Exchange Market

  • 9.1. China Therapeutic Plasma Exchange Market Overview
  • 9.2. China Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Therapeutic Plasma Exchange Market

  • 10.1. India Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Therapeutic Plasma Exchange Market

  • 11.1. Japan Therapeutic Plasma Exchange Market Overview
  • 11.2. Japan Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Therapeutic Plasma Exchange Market

  • 12.1. Australia Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Therapeutic Plasma Exchange Market

  • 13.1. Indonesia Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Therapeutic Plasma Exchange Market

  • 14.1. South Korea Therapeutic Plasma Exchange Market Overview
  • 14.2. South Korea Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Therapeutic Plasma Exchange Market

  • 15.1. Western Europe Therapeutic Plasma Exchange Market Overview
  • 15.2. Western Europe Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Therapeutic Plasma Exchange Market

  • 16.1. UK Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Therapeutic Plasma Exchange Market

  • 17.1. Germany Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Therapeutic Plasma Exchange Market

  • 18.1. France Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Therapeutic Plasma Exchange Market

  • 19.1. Italy Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Therapeutic Plasma Exchange Market

  • 20.1. Spain Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Therapeutic Plasma Exchange Market

  • 21.1. Eastern Europe Therapeutic Plasma Exchange Market Overview
  • 21.2. Eastern Europe Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Therapeutic Plasma Exchange Market

  • 22.1. Russia Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Therapeutic Plasma Exchange Market

  • 23.1. North America Therapeutic Plasma Exchange Market Overview
  • 23.2. North America Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Therapeutic Plasma Exchange Market

  • 24.1. USA Therapeutic Plasma Exchange Market Overview
  • 24.2. USA Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Therapeutic Plasma Exchange Market

  • 25.1. Canada Therapeutic Plasma Exchange Market Overview
  • 25.2. Canada Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Therapeutic Plasma Exchange Market

  • 26.1. South America Therapeutic Plasma Exchange Market Overview
  • 26.2. South America Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Therapeutic Plasma Exchange Market

  • 27.1. Brazil Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Therapeutic Plasma Exchange Market

  • 28.1. Middle East Therapeutic Plasma Exchange Market Overview
  • 28.2. Middle East Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Therapeutic Plasma Exchange Market

  • 29.1. Africa Therapeutic Plasma Exchange Market Overview
  • 29.2. Africa Therapeutic Plasma Exchange Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Therapeutic Plasma Exchange Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Therapeutic Plasma Exchange Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Therapeutic Plasma Exchange Market Competitive Landscape And Company Profiles

  • 30.1. Therapeutic Plasma Exchange Market Competitive Landscape
  • 30.2. Therapeutic Plasma Exchange Market Company Profiles
    • 30.2.1. Medica S.p.A. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Fresenius SE and Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Medtronic Plc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Asahi Kasei Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Toray Industries Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Therapeutic Plasma Exchange Market Other Major And Innovative Companies

  • 31.1. Baxter International Inc.
  • 31.2. B Braun Melsungen AG
  • 31.3. Terumo Corporation
  • 31.4. Kaneka Corporation
  • 31.5. Charles River Laboratories
  • 31.6. Octapharma AG
  • 31.7. Spectral Medical Inc.
  • 31.8. Nikkiso Co. Ltd.
  • 31.9. Haemonetics Corporation
  • 31.10. Miltenyi Biotec Technology And Trading Co. Ltd.
  • 31.11. Macopharma SA
  • 31.12. Cerus Corporation
  • 31.13. Apellis Pharmaceuticals Inc.
  • 31.14. ImmunoTek Bio Centers LLC
  • 31.15. CytoSorbents Corporation

32. Global Therapeutic Plasma Exchange Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Therapeutic Plasma Exchange Market

34. Recent Developments In The Therapeutic Plasma Exchange Market

35. Therapeutic Plasma Exchange Market High Potential Countries, Segments and Strategies

  • 35.1 Therapeutic Plasma Exchange Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Therapeutic Plasma Exchange Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Therapeutic Plasma Exchange Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer